XML 42 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Schedule II: Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2018
Valuation And Qualifying Accounts [Abstract]  
Schedule II: Valuation and Qualifying Accounts

Medical Properties Trust, Inc. and MPT Operating Partnership, L.P.

Schedule II: Valuation and Qualifying Accounts

December 31, 2018

 

 

 

 

 

 

 

Additions

 

 

 

Deductions

 

 

 

 

 

 

Year Ended December 31,

 

Balance at

Beginning of

Year(1)

 

 

Charged

Against

Operations(1)

 

 

 

Net

Recoveries/

Write-offs(1)

 

 

 

Balance at

End of Year(1)

 

 

 

(In thousands)

 

2018

 

$

16,397

 

 

$

57,285

 

(2)

 

$

(7,551

)

(3)

 

$

66,131

 

2017

 

$

18,852

 

 

$

2,525

 

(4)

 

$

(4,980

)

(5)

 

$

16,397

 

2016

 

$

27,384

 

 

$

2,722

 

(6)

 

$

(11,254

)

(7)

 

$

18,852

 

 

(1)

Includes allowance for doubtful accounts, straight-line rent reserves, allowance for loan losses, tax valuation allowances and other reserves.

(2)

Represents $48 million increase to real estate impairment reserve and $9.3 million increases in accounts receivable reserves during 2018.

(3)

Includes $7.7 million decrease in valuation allowance (which includes the $4.4 million release of domestic valuation allowances in the 2018 fourth quarter) that was originally recorded to reserve against our net deferred tax assets.

(4)

Represents increases in accounts receivable reserves during 2017.

(5)

Includes $4.9 million decrease in valuation allowance that was originally recorded to reserve against our net deferred tax assets.

(6)

Includes $1.9 million of rent reserves related to our Twelve Oaks facility and $0.8 million of rent reserves related to our Corinth facility.

(7)

Includes write-offs of $3.3 million related to payment of rent, late fees, and loans for our Twelve Oaks facility; $0.8 million of write-offs for rent and interest reserves related to the sale of the Corinth facility; $0.1 million of write-offs related to the McLeod Healthcare loan; and $6.1 million decrease in valuation allowances (which includes the $4 million release of foreign valuation allowances in the 2016 fourth quarter) that was originally recorded to reserve against our net deferred tax assets.